NEUROCRINE BIOSCIENCES INC's ticker is and the CUSIP is 64125CAD1.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $4,694,590 | +17.7% | 3,125,000 | 0.0% | 0.16% | +13.3% |
Q2 2023 | $3,989,479 | -5.8% | 3,125,000 | 0.0% | 0.14% | -4.0% |
Q1 2023 | $4,235,941 | -14.6% | 3,125,000 | 0.0% | 0.15% | -34.6% |
Q4 2022 | $4,960,077 | +39.8% | 3,125,000 | +25.0% | 0.23% | +41.6% |
Q3 2022 | $3,547,000 | +113.7% | 2,500,000 | +100.0% | 0.16% | +177.6% |
Q2 2022 | $1,660,000 | – | 1,250,000 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CSS LLC/IL | 15,659,000 | $23,207,687 | 1.52% |
SONA ASSET MANAGEMENT (US) LLC | 17,500,000 | $26,317,952 | 1.09% |
TENOR CAPITAL MANAGEMENT Co., L.P. | 26,765,000 | $40,113,099 | 0.86% |
Warberg Asset Management LLC | 1,271,000 | $1,885,846 | 0.38% |
SSI INVESTMENT MANAGEMENT LLC | 2,296,000 | $3,406,116 | 0.28% |
Paloma Partners Management Co | 3,125,000 | $4,694,590 | 0.16% |
FRANKLIN RESOURCES INC | 54,750,000 | $81,769,125 | 0.04% |
Rock Springs Capital Management LP | 1,000,000 | $1,497,950 | 0.04% |
LORD, ABBETT & CO. LLC | 4,666,000 | $6,922 | 0.03% |
D. E. Shaw & Co., Inc. | 14,351,000 | $21,373,197 | 0.02% |